Investigational treatment improves outcomes without complete complement blockade ...

If you dream of a country-inspired outdoor kitchen, find out how to create one in your garden. Keep reading for outdoor ...

Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced the ...

Good morning, and welcome to Otis' First Quarter 2026 Earnings Conference Call. This call is being carried live over the Internet and recorded for replay. Presentation materials are available for ...

Marvell (MRVL) stock jumped 6.3% premarket on news of Google partnership to develop AI chips including a memory processing ...

Explore the stark contrasts emerging between aging designs and ambitious new programs.

Google launches AI agent suite at Cloud Next 2026 with Workspace Studio, A2A protocol at 150 orgs, and Project Mariner. The pitch: only Google owns the full stack.

Olverembatinib, an investigational multikinase inhibitor (approved in China for CML), inhibits Src-family kinases (e.g., Lyn, ...

The introduction of Security Constrained Economic Dispatch (SCED) by the National Load Dispatch Center (NLDC) in 2019 has ...

This Pennsylvania café serves a one-of-a-kind breakfast item you won’t find anywhere else, making it a must-try this April.

Argenx Brings Neuromuscular Leadership To AAN 2026 With New Data Supporting Broader VYVGART Use Across MG And CIDP. <li /> ADAPT OCULUS is the first study to evaluate a targeted treatment for ocular ...

Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic ...